Central Trust Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
5,612
-15
-0.3% -$1.09K 0.01% 483
2026
Q1
$367K Sell
5,627
-305
-5% -$22.7K 0.01% 487
2025
Q4
$470K Sell
5,932
-348
-6% -$26.7K 0.01% 437
2025
Q3
$458K Buy
6,280
+65
+1% +$4.76K 0.01% 439
2025
Q2
$471K Sell
6,215
-157
-2% -$11.1K 0.01% 426
2025
Q1
$485K Sell
6,372
-515
-7% -$38.4K 0.01% 410
2024
Q4
$455K Sell
6,887
-402
-6% -$28.1K 0.01% 425
2024
Q3
$508K Sell
7,289
-982
-12% -$59.1K 0.01% 405
2024
Q2
$437K Buy
+8,271
New +$502K 0.01% 427

Other funds holding SOLV

Central Trust Company's SOLV Position: Q2 2026 in Review

Central Trust Company reduced its Solventum (SOLV) stake by 0.27% in Q2 2026, selling an estimated $1.09K and leaving 5,612 shares worth $433K. The position accounts for 0.01% of the portfolio, ranked #483.

Central Trust Company first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $508K in Q3 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Central Trust Company held 5,612 shares of Solventum worth $433K as of Q2 2026.
  • Central Trust Company sold 15 Solventum shares in Q2 2026, an estimated $1.09K.
  • Solventum made up 0.01% of Central Trust Company's portfolio in Q2 2026, its #483 holding.
  • Central Trust Company first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Central Trust Company's Solventum position peaked at $508K in Q3 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.